Cart
sales@molnova.com
Moguisteine
CAS No. 119637-67-1
Moguisteine( BBR-2173 | BBR2173 | BBR 2173 )
Catalog No. M10692 CAS No. 119637-67-1
Moguisteine is a novel peripheral non-narcotic antitussive drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMoguisteine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMoguisteine is a novel peripheral non-narcotic antitussive drug.
-
DescriptionMoguisteine is a novel peripheral non-narcotic antitussive drug.
-
In Vitro——
-
In Vivo——
-
SynonymsBBR-2173 | BBR2173 | BBR 2173
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number119637-67-1
-
Formula Weight339.41
-
Molecular FormulaC16H21NO5S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 68 mg/mL (200.34 mM); DMSO: 68 mg/mL (200.34 mM)
-
SMILESO=C(OCC)CC(N1C(COC2=CC=CC=C2OC)SCC1)=O
-
Chemical Nameethyl 3-(2-((2-methoxyphenoxy)methyl)thiazolidin-3-yl)-3-oxopropanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gallico L, et al. Br J Pharmacol, 1994, 112(3), 795-800.
molnova catalog
related products
-
Tirasemtiv
Tirasemtiv(CK 2017357) is a small-molecule fast-skeletal-troponin activator, with a potential treatment for muscle weakness and neuromuscular dysfunction.
-
Boc-MLF
Antagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
-
N-Benzyllinoleamide
N-Benzyllinoleamide is a natural product isolated from Lepidium meyenii Walp, has pharmaceutical property against exercise-induced fatigue.
